An analyst note raising questions about Amgen’s MariTide triggered a stock sell-off Tuesday. Elsewhere, Roche and Novartis ...
The company is also raising its full-year guidance to $14.9 billion in adjusted EBITDA, an 8.8% increase from its last ...
Alex Newman screens for the best eight investment trust ideas that cover the world's most important stock markets ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback